Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.04
-0.09-2.88%
At close: -
$3.37
0.3310.86%
After Hours: Mar 24, 8:49 AM EDT
Comments
Loading...
HeartSciences Analyst Ratings and Price Targets | NASDAQ:HSCS | Benzinga
HeartSciences Inc has a consensus price target of $9.32 based on the ratings of 4 analysts. The high is $14 issued by Ascendiant Capital on March 18, 2025. The low is $3.3 issued by Ascendiant Capital on January 30, 2023. The 3 most-recent analyst ratings were released by Ascendiant Capital, Maxim Group, and Ascendiant Capital on March 18, 2025, December 18, 2024, and September 23, 2024, respectively. With an average price target of $13.67 between Ascendiant Capital, Maxim Group, and Ascendiant Capital, there's an implied 305.54% upside for HeartSciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Ascendiant Capital
Maxim Group
Ascendiant Capital
Benchmark
1calculated from analyst ratings
Analyst Ratings for HeartSciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | Buy Now | 315.43% | Ascendiant Capital | Lucas Ward22% | $15 → $14 | Maintains | Buy | Get Alert |
| 12/18/2024 | Buy Now | 256.08% | Maxim Group | Allen Klee36% | $12 → $12 | Reiterates | Buy → Buy | Get Alert |
| 09/23/2024 | Buy Now | 345.1% | Ascendiant Capital | Lucas Ward22% | $15 → $15 | Reiterates | Buy → Buy | Get Alert |
| 01/30/2023 | Buy Now | -2.08% | Ascendiant Capital | Edward Woo52% | → $330 | Initiates | → Buy | Get Alert |
| 12/19/2022 | Buy Now | -10.98% | Maxim Group | Allen Klee36% | $800 → $300 | Maintains | Buy | Get Alert |
| 11/09/2022 | Buy Now | 137.39% | Maxim Group | Allen Klee36% | → $800 | Initiates | → Buy | Get Alert |
| 08/08/2022 | Buy Now | 137.39% | Benchmark | Bruce Jackson42% | → $800 | Initiates | → Speculative Buy | Get Alert |
FAQ
What is the target price for HeartSciences (HSCS) stock?
The latest price target for HeartSciences (NASDAQ:HSCS) was reported by Ascendiant Capital on March 18, 2025. The analyst firm set a price target for $14.00 expecting HSCS to rise to within 12 months (a possible 315.43% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for HeartSciences (HSCS)?
The latest analyst rating for HeartSciences (NASDAQ:HSCS) was provided by Ascendiant Capital, and HeartSciences maintained their buy rating.
When was the last upgrade for HeartSciences (HSCS)?
There is no last upgrade for HeartSciences
When was the last downgrade for HeartSciences (HSCS)?
There is no last downgrade for HeartSciences.
When is the next analyst rating going to be posted or updated for HeartSciences (HSCS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HeartSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HeartSciences was filed on March 18, 2025 so you should expect the next rating to be made available sometime around March 18, 2026.
Is the Analyst Rating HeartSciences (HSCS) correct?
While ratings are subjective and will change, the latest HeartSciences (HSCS) rating was a maintained with a price target of $15.00 to $14.00. The current price HeartSciences (HSCS) is trading at is $3.37, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.